Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

NCT07214298 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
35
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Roswell Park Cancer Institute